NCT05779319 is a clinical trial of non contact measurement with the IOL Master 700 in Cataract, sponsored by Johannes Kepler University of Linz.

Who is sponsoring NCT05779319?

NCT05779319 is sponsored by Johannes Kepler University of Linz.

What drugs are being tested in NCT05779319?

Interventions in NCT05779319: non contact measurement with the IOL Master 700.

Is NCT05779319 still recruiting?

NCT05779319 is currently status unknown. Last updated 5 October 2023.

Last reviewed 2023-10-05 · How we verify

NCT05779319

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1000 Eyes Lens Biometry Study: Artificial Intelligence for Intraocular Lens Power Calculation

Status unknown Last updated 5 October 2023

What this trial tests

trial testing non contact measurement with the IOL Master 700 in Cataract in 1,000 participants. Status unknown.

Timeline

1 February 2022

Primary endpoint
30 July 2024

30 September 2025

Quick facts

Lead sponsor	Johannes Kepler University of Linz
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	1 February 2022
Primary completion	30 July 2024
Estimated completion	30 September 2025
Sites	1 location across Austria

Drugs / interventions tested

non contact measurement with the IOL Master 700

Conditions studied

Cataract — all drugs for Cataract →

Sponsor

Johannes Kepler University of Linz

Who can join

Adults 21 to 110, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of the study is to develop an AI approach to improve intraocular lens power calculations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cataract

Currently open trials in the same condition.

NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting

Other Johannes Kepler University of Linz trials

Trials by the same sponsor.

NCT07202767 — Intraocular Lens Calculation Using Artificial Intelligence · not yet recruiting
NCT07210372 — Axial Stability in Short and Long Eyes After Cataract Surgery · completed
NCT06595693 — Tilt Prediction of Clareon Intraocular Lens · completed
NCT05719532 — Core Strength and Coordinative Skills · unknown
NCT05769543 — WATSU and Body Awareness · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05779319 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johannes Kepler University of Linz
Last refreshed: 5 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05779319.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing